Perspective Therapeutics, Inc. (CATX)
AMEX
Healthcare
Medical - Devices
$3.42
▼ -5.26%
Market Cap
$264.2M
Sector
Healthcare
Industry
Medical - Devices
Beta
1.75
52-Wk Range
1.96-6.16
CEO
Johan Spoor
Country
US
Currency
USD
Perspective Therapeutics, Inc., including its various operations, specializes in the comprehensive lifecycle – from development and manufacturing to sales and marketing – of radiopharmaceutical products and medical devices. These advanced solutions are designed to treat cancer and other serious malignant conditions, serving markets both within the United States and globally. A flagship product offered by the company is its CS-1 Cesium-131 brachytherapy seeds. This treatment is specifically utilized for a broad range of cancers, such as those impacting the prostate, brain, lung, head and neck r…
Open full interactive analysis & DCF →